Cargando…
Safety and effectiveness of vascular closure devices in interventional radiological procedures
BACKGROUND: Although it is well known that vascular closure devices (VCD) are commonly used in therapeutic interventional radiological procedures, standard use in diagnostic procedures is not as well studied. PURPOSE: The aim of this study was to determine the real-world safety and effectiveness of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549703/ https://www.ncbi.nlm.nih.gov/pubmed/35538887 http://dx.doi.org/10.1177/15910199221100628 |
Sumario: | BACKGROUND: Although it is well known that vascular closure devices (VCD) are commonly used in therapeutic interventional radiological procedures, standard use in diagnostic procedures is not as well studied. PURPOSE: The aim of this study was to determine the real-world safety and effectiveness of the VCD in both diagnostic and therapeutic interventional radiological procedures. MATERIALS AND METHODS: A retrospective, single center study included all patients where VCDs were used for either a diagnostic or therapeutic interventional procedure. Various demographic and clinical risk factors were recorded and examined for any significant association with successful deployment and complications. RESULTS: A total of 2072 patients were included. VCDs were successfully deployed in 95.2% of the patients with 4.8% of perioperative complications, which included minor oozing from the puncture site, small hematoma less than or equal to 5 cm, large hematoma greater than 5 cm, pain, and loss of vascular access. Therapeutic (vascular interventional radiology (VIR) and neuro-interventional radiology (NIR)) procedures (OR 3.03, 95% CI 1.51–6.09, p = 0.002), use of Angioseal (OR 5.26, 95% CI 3.13–8.33), p < 0.001), and no use of antiplatelet medications (OR 0.47, 95% CI 0.22–0.97, p = 0.041) were independently associated with successful deployment of VCDs when controlled for other risk factors. Smoking (OR 3.50, 95% CI 2.00–6.05, p = <0.001), use of antiplatelet (OR 2.01, 95% CI 1.04–3.87, p = 0.037) and use of heparin (OR 1.78, 95% CI 1.10–2.86, p = 0.018) were independently associated with higher complication rates. CONCLUSION: VCD's were successfully deployed in 95.2% of the patients with 4.8% of perioperative minor complications. |
---|